Profile
Full Name
Seelos Therapeutics, Inc.Ticker
NASDAQ: SEELExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
April 19, 1999Indexes
Not includedEmployees
8Key Details
Price
-
Market cap
-
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$2.20M(+100.00% YoY)
Annual EPS
-$989.44(+62.66% YoY)
PE ratio
-
Next earnings date
N/ANext ex-dividend date
N/ANext split date
N/AQuick Search
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Analyst ratings
Price
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Seelos Therapeutics, Inc. doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Sep 22, 23 Guggenheim
NeutralSep 21, 23 Guggenheim
NeutralSep 21, 23 Cantor Fitzgerald
NeutralSep 21, 23 Benchmark
Speculative BuyAug 22, 23 Cantor Fitzgerald
OverweightAug 15, 23 Cantor Fitzgerald
OverweightJun 23, 23 Cantor Fitzgerald
OverweightJun 23, 23 Benchmark
Speculative BuyJun 13, 23 BTIG
BuyMay 16, 23 Cantor Fitzgerald
OverweightInstitutional Ownership
Screeners with SEEL included
No data
- What is the ticker symbol for Seelos Therapeutics, Inc.?
- Does Seelos Therapeutics, Inc. pay dividends?
- What sector is Seelos Therapeutics, Inc. in?
- What industry is Seelos Therapeutics, Inc. in?
- What country is Seelos Therapeutics, Inc. based in?
- When did Seelos Therapeutics, Inc. go public?
- Is Seelos Therapeutics, Inc. in the S&P 500?
- Is Seelos Therapeutics, Inc. in the NASDAQ 100?
- Is Seelos Therapeutics, Inc. in the Dow Jones?
- When was Seelos Therapeutics, Inc.'s last earnings report?
- When does Seelos Therapeutics, Inc. report earnings?
What is the ticker symbol for Seelos Therapeutics, Inc.?
The ticker symbol for Seelos Therapeutics, Inc. is NASDAQ:SEEL
Does Seelos Therapeutics, Inc. pay dividends?
No, Seelos Therapeutics, Inc. does not pay dividends
What sector is Seelos Therapeutics, Inc. in?
Seelos Therapeutics, Inc. is in the Healthcare sector
What industry is Seelos Therapeutics, Inc. in?
Seelos Therapeutics, Inc. is in the Biotechnology industry
What country is Seelos Therapeutics, Inc. based in?
Seelos Therapeutics, Inc. is headquartered in United States
When did Seelos Therapeutics, Inc. go public?
Seelos Therapeutics, Inc.'s initial public offering (IPO) was on April 19, 1999
Is Seelos Therapeutics, Inc. in the S&P 500?
No, Seelos Therapeutics, Inc. is not included in the S&P 500 index
Is Seelos Therapeutics, Inc. in the NASDAQ 100?
No, Seelos Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Seelos Therapeutics, Inc. in the Dow Jones?
No, Seelos Therapeutics, Inc. is not included in the Dow Jones index
When was Seelos Therapeutics, Inc.'s last earnings report?
Seelos Therapeutics, Inc.'s most recent earnings report was on November 21, 2024
When does Seelos Therapeutics, Inc. report earnings?
The date for Seelos Therapeutics, Inc.'s next earnings report has not been announced yet